Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GFH018 |
Synonyms | |
Therapy Description |
GFH018 inhibits TGFBR1, leading to decreased downstream signaling, and potentially resulting in modulation of immune response, decreased tumor cell migration, reduced angiogenesis, and antitumor activity (Cancer Res 2019;79(13 Suppl):Abstract nr 3072). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GFH018 | GFH-018|GFH 018 | TGFBR1 inhibitor 16 | GFH018 inhibits TGFBR1, leading to decreased downstream signaling, and potentially resulting in modulation of immune response, decreased tumor cell migration, reduced angiogenesis, and antitumor activity (Cancer Res 2019;79(13 Suppl):Abstract nr 3072). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|